Stabilization

FDA clearance brings liquid biopsy into a new era

With the FDA clearance of several assays, liquid biopsy moves closer toward the goal of making this screening method a standard of care. Liquid biopsy…
Read More
Stabilization

How can nucleic acids predict disease?

Liquid biopsy is a diagnostic technique where bodily fluids are examined for biomarkers that suggest disease. In recent years, liquid biopsy has been …
Read More
Why stabilization matters
Stabilization

Why does stabilization matter?

Human blood is packed with genetic information found in circulating cell-free DNA (cfDNA) and cell-free RNA (RNA). Liquid biopsy takes advantage of th…
Read More
Stabilization

ARM-D Kits for wastewater workflow

Streck exhibited and presented at the globally represented European Congress of Clinical Microbiology & Infectious Diseases in Copenhagen, Denmark…
Read More
Sequencing DNA
Stabilization

FDA drafts guidance on ctDNA

Earlier this year, the U.S. Food and Drug Administration released a draft guidance regarding the use of circulating tumor DNA (ctDNA) for early-stage …
Read More
Stabilization

Cyto-Chex BCT – PBMC Isolation

Streck Cyto-Chex® BCT effectively stabilizes immunomagnetic isolated Peripheral Blood Mononuclear Cells (PBMCs) for up to 7 days post blood collectio…
Read More
Stabilization

Urine: a great biofluid for biomarkers

COVID-19 testing has brought non-blood based biological samples into the everyday life of researchers and people around the world. Before this new wav…
Read More
Stabilization

Cleared assays advance liquid biopsy

The goal of liquid biopsy moved closer to reality in past weeks. Liquid biopsy is the use of a bodily fluid to collect information from a distant site…
Read More
Stabilization

microRNA in RNA Complete BCT

Streck recently presented data on our new and innovative blood collection tube, RNA Complete BCT®, at the American Association for Cancer Research (A…
Read More